rulperidone

rulperidone (munupati abhivruddhi sanketanamalu mini-101, sair-101, enti-210) anedi schizophrenia chikitsa kosam minerwa neurosciences abhivruddhi chestunna 5-hetch tii 2 eah mariyu sii ess 2 grahaka virodhi. daani gvakriyalo okadaaniki kooda kooda graahakamtho kontha anubandham undhi. prii-clinical phalitaalu medadu-utpannamaina neurotrophic karakam ("bdnf") paie rulperidone prabhaavaaniki sakshyalanu andistaayi, idhi neurogenesis, neuroplasticity, neuroprotection, synaps regulation, learning mariyu memariitoe mudipadi undhi. 2018 mae natiki, eee aushadham moodava dasha clinical trialslo undhi. 2020 maeloe, mainarwa neurosciences yokka vaatalu 67 saatam padipoyayi, vichaarana "pratikuula lakshanaalalo taggimpu yokka praathamika mugimpu binduvunu cherukovadamlo viphalamaindi, mariyu vyaktigata mariyu saamaajika paniteeru kolatalalo merugudala yokka keelaka dviteeya mugimpu binduvulu."ayithe, 2022 augustulo minerwa schizophrenia chikitsa kosam rolperidone aamodam kosam phud und drugg administration (fda) kuu kotta aushadha darakhaastunu (nda) samarpinchindi. 2022 praarambhamlo prachurinchabadina moodava dasha clinical trialnu vijayavantamgaa puurti chesina taruvaata october nda samarpana jarigindi. eee rendava vichaarana yokka phalitaalu schizophrenialo pratikuula lakshanaala chikitsaku eee aushadham samarthavanthamaina agent anae vaadanaku maddatu istayani minerwa nammadu. ayithe, schizophrenia rogulalo pratikuula lakshanaalaku chikitsa cheyadaaniki rulperidone kosam kotta aushadha darakhaastuku sambandhinchi lekhanu daakhalu cheyadaaniki niraakaristuu october october eff. dii. yea. minarvaaku pampindi. 

